13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001012975-23-000467
Total Value
$458.1M
Positions
12
Other Managers
0
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR GOLD TR | GLD | 1,062,500 | $182.2M | 39.76% |
| 2 | ISHARES TR | 46429B598 | 2,425,144 | $107.2M | 23.41% |
| 3 | SPDR S&P 500 ETF TR | SPY | 246,250 | $105.3M | 22.98% |
| 4 | PMV PHARMACEUTICALS INC | PMVP | 2,627,643 | $16.1M | 3.52% |
| 5 | RAPT THERAPEUTICS INC | 75382E109 | 657,899 | $10.9M | 2.39% |
| 6 | 23ANDME HOLDING CO | 90138Q108 | 10,243,122 | $10.0M | 2.19% |
| 7 | ALECTOR INC | ALEC | 1,307,858 | $8.5M | 1.85% |
| 8 | FOGHORN THERAPEUTICS INC | FHTX | 1,573,761 | $7.9M | 1.72% |
| 9 | ORIC PHARMACEUTICALS INC | ORIC | 989,410 | $6.0M | 1.31% |
| 10 | TENAYA THERAPEUTICS INC | TNYA | 1,015,705 | $2.6M | 0.57% |
| 11 | NGM BIOPHARMACEUTICALS INC | 62921N105 | 992,168 | $1.1M | 0.23% |
| 12 | SURROZEN INC | SRZNW | 802,963 | $393,452 | 0.09% |